当前位置：   首页 > 需求大厅

需要近几年国内抗病毒市场销售情况、主要品种等。   [更多]

再生药的发展领域，主要集中在修复和取代受损细胞组织或病源组织。干细胞有自我修复功能。胚胎干细胞可以开发成身体内任何形式的细胞组织，成体干细胞的功能是维护或修复身体内部的细胞。Boiheringer Ingelheim的寻找目标是：调动，刺激，分化新的内源性干细胞分子结构的途径。 投标截止时期2016年6月24日, 投标网址：https://www.innocentive.com/ar/challenge/9933855 原文 Mobilization, Stimulation, and Differentiation of Endogenous Stem Cells TAGS: Chemistry, Royal Society of Chemistry, Life Sciences, Ideation AWARD: $15,000 USD | DEADLINE: 6/24/16 | ACTIVE SOLVERS: 51 | POSTED: 4/25/16 1. The Challenge and qualification for the award During early development, embryonic stem cells are undifferentiated cells that can be stimulated to proliferate and develop into all different cell types. In adults, these endogenous cells are found in tissues and they can divide either to replenish the stem cell population or differentiate into specialized cells of the tissue in which they reside. These adult stem cells function as an internal maintenance or repair system, so it would be beneficial to be able to direct and enhance this regenerative capacity. Therefore, Boehringer Ingelheim (the Seeker) desires the identification of new molecular mechanisms and pathways involved in mobilization, stimulation, and differentiation of endogenous stem cells. All submitted solutions will be considered for the award. There will be a guaranteed award for at least one submitted solution. The total payout will be $15,000, with the possibility to distribute it amongst one or more Solvers, with at least one award being no smaller than $5,000 and no award being smaller than $1,000. 2. Additional application for Research Funding In addition to consideration for the award for the submitted solutions, Solvers with appropriate qualifications and expertise having access to a suitable research laboratory and equipment can apply for research funding (“Research Funding”) to execute the research plan that is proposed in the solution. The selection of candidates for Research Funding will be conducted after completion of this Challenge   [更多]

为健康动物做明显标记的染料或颜料，通常有以下2种限制： 1. 染料往往是活性的，因此不容易褪色，并有强烈的产品活性成分。 2. 颜料活性低，不粘附皮肤，所以容易被清洗。 目标要求是研发一种能在动物体上染色的环保材料（如：染料，颜料或其他） 或者一种配方能够达到相同效果。 投标截止时期2016年5月29日, 投标网址https://www.innocentive.com/ar/challenge/9933850 原文 Challenge Overview The Seeker to this Challenge has a cleaning product for animal hygiene to which the Seeker intends to add the capability to stain skin with a clear, visible mark. Various dyes and pigments exist with the potential to provide this feature, however two limitations have been found: • Dyes tend to be reactive, hence not staining and consuming the active ingredient of the product. • Pigments are less reactive, do not adhere to skin, and are therefore easily washed out. The Challenge is to develop a highly colored version of the cleaning product adding to it the ability to stain animal skin. Hence, the Seeker is looking for ideas for ingredients (dyes, pigments, or others) and/or formulations that can overcome the above identified limitations and achieve this effect. This is a Theoretical Challenge that requires only a written proposal to be submitted. The Challenge award will be contingent upon theoretical evaluation of the proposal by the Seeker. Submissions to this Challenge must be received by 11:59 PM (US Eastern Time) on May 29, 2016. Late submissions may not be considered. To receive an award, the Solvers will have to transfer to the Seeker their exclusive Intellectual Property (IP) rightsto the solution.   [更多]

防粘连产品属于三类医疗器械，现需要其终端医院销售数据、市场分析等方面信息。具体价格再议。   [更多]

理论分析一种材料，能有明显区分其与丙酮或水（潮湿）的物理作用。如膨胀，收缩，卷曲，等等。此材料不限于纤维，膜剂或织物。 “请于2016年5月23日之前将稿件上传到：https://www.innocentive.com/ar/challenge/9933858 “ Challenge Overview Many materials (usually polymers) change shape when exposed to acetone (ketones in general) but also have a large affinity for moisture as well. It would be very difficult to attribute physical changes to acetone or water if both were present. The Seeker is looking for materials and associated processes that produce an observable physical change to the substrate upon exposure to acetone. The material should not have the same effect when exposed to moisture so the two can be differentiated. The effect should be reversible and the rate of absorb/desorb should be similar. This is a Theoretical Challenge that requires only a written proposal to be submitted. The Challenge award will be contingent upon theoretical evaluation of the proposal by the Seeker. To receive an award, the Solvers will have to transfer to the Seeker their exclusive Intellectual Property (IP) rightsto the solution. However, the Seeker will be willing to consider a licensing agreement for a partial award if exclusive IP cannot be transferred by the Solver. Submissions to this Challenge must be received by 11:59 PM (US Eastern Time) on May 23, 2016. Late submissions will not be considered.   [更多]

环磷酰胺、骨陶瓷材料、抗辐射药氨磷汀、福辛普利 唑来膦酸   [更多]

不过期的，   [更多]

我需要USP38 的 1843-1844两页的扫描件或图片，附件是我看到的目录，   [更多]

招募急性痛风性关节炎志愿者 招募概述： 如果您是急性痛风性关节炎患者，符合以下条件就可以报名参加虎贞痛风胶囊的临床研究。虎贞痛风胶囊由广东一力集团制药有限公司/广州暨南生物医药研究开发基地有限公司研制并提供的，并于2008年经国家食品药品监督管理局批准进行临床研究，临床试验批件号：2008L02043。其具有清热利湿，化瘀利浊，滋补肝肾的功效。主治急性痛风性关节炎（湿热蕴结证），症见：关节红肿热痛，伴有发热，汗出不解，口渴喜饮，心烦不安，小便黄及痛风病见上述症候者。此研究由中国中医科学院广安门医院等15家医院共同参与。 如果您愿意参加本项研究并通过筛选符合条件，我们将为您提供3天的免费治疗并免费进行相关检查（包含：体格检查、血常规、尿常规、便常规、肝肾功、心电图、血尿酸、类风湿因子、血沉、C反应蛋白和抗链球菌溶血素‘O’）。 入选条件： 1.符合急性痛风性关节炎诊断标准，且辨证为湿热蕴结证。 2.急性发作在48小时之内，本次发作未用过治疗药（包括秋水仙碱、非甾类抗炎药及激素等）者。 3.VAS评分≥4分。 4.年龄18-65岁。 5.签署知情同意书。 您一旦参加本试验将获得较全面的检查和试验药物治疗，并将得到医生的全面跟踪随访。 如您符合纳入标准，并有意参加本研究项目，请到辽宁中医药大学第二附属医院住院部A楼三楼糖尿病科咨询 。 地址：沈阳市皇姑区黄河北大街60号 联系方式：江红主任：138 4008 4568 马尧医生：139 4046 6290   [更多]

罕见癌症研究基金会(RCRF),致力于通过战略投资和创新合作进行基础治疗罕见的癌症,和美国文化募捐组织(ATCC),世界上最大的非营利性细胞株库,建立神经内分泌肿瘤细胞株收集目录。肠道良性肿瘤和胰腺神经内分泌肿瘤(PNET)需求一种新疗法的研究和发展，即在体内原发性肿瘤中建立新的细胞株。 为了刺激发展新的良性肿瘤和PNET细胞系,该基金会是高兴地宣布第二次开放竞争十个人奖项:开发人员的第一个新的细胞系在每个疾病(肠道良性肿瘤和PNET)将获得100000美元，开发者的第二,第三,第四,第五个新细胞系在每个疾病将会收到50000美元。原文如下：https://www.innocentive.com/ar/challenge/9933756 The lack of well-validated and widely accepted cell lines derived from intestinal carcinoid and pancreatic neuroendocrine tumors (PNET) is a significant barrier for research and development of new therapies. The Caring for Carcinoid Foundation therefore wishes to launch a second Challenge to stimulate a concerted effort to create a “collection” of well-characterized cell lines that faithfully replicate tumor characteristics and genetics. The Foundation has partnered with the Rare Cancer Research Foundation (RCRF), a foundation dedicated to curing rare cancers through strategic investments and innovative collaborations, and the American Type Culture Collection (ATCC), the world’s largest non-profit cell line repository, to establish a Neuroendocrine Tumor Cell Line collection in their catalog. This is a Reduction-to-Practice Challenge that requires written documentation, detailed description of each cell line, and sample delivery. Source: InnoCentive Challenge ID: 9933756 Challenge Overview This Challenge is intended to encourage innovative approaches to establishing new cell lines from primary tumors that grow slowly in vivo and to publicize new methods as well as availability of the new cell lines for broad, unrestricted use. To stimulate development of new carcinoid and PNET cell lines, the Foundation is pleased to announce its second open competition for up to ten individual prizes: Developers of the first new cell lines in each disease (intestinal carcinoid and PNET) will receive $100,000 each and developers of the second, third, fourth, and fifth new cell lines in each disease will receive $50,000 each. Individual   [更多]